Liu Yanjun, Nakagawa Yuichi, Wang Ying, Li Renshan, Li Xiaojun, Ohzeki Takehiko, Friedman Theodore C
Division of Endocrinology, Charles R. Drew University of Medicine & Sciences, UCLA School of Medicine, 1731 E. 120th Street, Los Angeles, CA 90059, USA.
Diabetes. 2003 Jun;52(6):1409-16. doi: 10.2337/diabetes.52.6.1409.
Glucocorticoids have been implicated as pathophysiological mediators of obesity and insulin resistance and are regulated by 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1). This enzyme regenerates active corticosterone from inactive 11-keto forms. To assess the role of 11beta-HSD1-mediated synthesis of active corticosterone in leptin-related obesity and diabetes, we examined the peripheral effect of leptin on 11beta-HSD1 activity and gene expression in vivo and in vitro in hepatocytes from ob/ob mice and in liver of streptozotocin (STZ)-treated ob/ob mice. We observed an inverse relationship between hepatic 11beta-HSD1 expression and body weight in ob/ob mice and lean littermates. Leptin treatment of ob/ob mice markedly increased hepatic 11beta-HSD1 activity and mRNA expression. This induction of 11beta-HSD1 expression corresponded to reduced levels of circulating corticosterone and weight loss in ob/ob mice treated with leptin, indicating that impaired hepatic 11beta-HSD1 expression may contribute to the pathogenesis of obesity in ob/ob mice. In addition, leptin treatment of STZ-treated ob/ob mice caused marked increases in hepatic 11beta-HSD1 levels associated with decreased body weight and a significant reduction in hyperglycemia due to pancreatic beta-cell damage. Addition of leptin to ob/ob mouse primary hepatocytes led to a dose-dependent increase in 11beta-HSD1 mRNA expression. In contrast, leptin did not influence 11beta-HSD1 expression in primary hepatocytes from db/db mice, indicating that leptin regulation of 11beta-HSD1 expression is probably mediated by the functional leptin receptor. Thus, leptin appears to be an important metabolic signal that directly activates intrahepatic corticosterone production. These findings suggest that the liver-specific interaction of leptin with 11beta-HSD1 is involved in the development of obesity and insulin resistance in ob/ob mice.
糖皮质激素被认为是肥胖和胰岛素抵抗的病理生理介质,并受11β-羟基类固醇脱氢酶1型(11β-HSD1)调节。该酶可将无活性的11-酮形式再生为活性皮质酮。为了评估11β-HSD1介导的活性皮质酮合成在瘦素相关肥胖和糖尿病中的作用,我们在体内和体外研究了瘦素对ob/ob小鼠肝细胞以及链脲佐菌素(STZ)处理的ob/ob小鼠肝脏中11β-HSD1活性和基因表达的外周影响。我们观察到ob/ob小鼠和瘦的同窝小鼠肝脏中11β-HSD1表达与体重呈负相关。用瘦素处理ob/ob小鼠可显著增加肝脏11β-HSD1活性和mRNA表达。11β-HSD1表达的这种诱导与瘦素处理的ob/ob小鼠循环皮质酮水平降低和体重减轻相对应,表明肝脏11β-HSD1表达受损可能促成ob/ob小鼠肥胖的发病机制。此外,用瘦素处理STZ处理的ob/ob小鼠会导致肝脏11β-HSD1水平显著升高,同时体重减轻,并且由于胰腺β细胞损伤导致的高血糖症显著降低。向ob/ob小鼠原代肝细胞中添加瘦素会导致11β-HSD1 mRNA表达呈剂量依赖性增加。相比之下,瘦素不影响db/db小鼠原代肝细胞中11β-HSD1的表达,表明瘦素对11β-HSD1表达的调节可能由功能性瘦素受体介导。因此,瘦素似乎是一种直接激活肝内皮质酮产生的重要代谢信号。这些发现表明,瘦素与11β-HSD1在肝脏中的特异性相互作用参与了ob/ob小鼠肥胖和胰岛素抵抗的发展。